159 related articles for article (PubMed ID: 29327939)
1. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
Ajona D; Zandueta C; Corrales L; Moreno H; Pajares MJ; Ortiz-Espinosa S; Martínez-Terroba E; Perurena N; de Miguel FJ; Jantus-Lewintre E; Camps C; Vicent S; Agorreta J; Montuenga LM; Pio R; Lecanda F
Am J Respir Crit Care Med; 2018 May; 197(9):1164-1176. PubMed ID: 29327939
[TBL] [Abstract][Full Text] [Related]
2. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E
Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
[TBL] [Abstract][Full Text] [Related]
3. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
[TBL] [Abstract][Full Text] [Related]
4. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
Front Immunol; 2021; 12():652242. PubMed ID: 33936074
[TBL] [Abstract][Full Text] [Related]
5. The C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
Shah DS; McNeilly AD; McCrimmon RJ; Hundal HS
Cell Signal; 2024 Jan; 113():110944. PubMed ID: 37890688
[TBL] [Abstract][Full Text] [Related]
6. C5a/C5aR1 axis as a key driver promotes epithelial-to-mesenchymal transition in airway epithelial cells in silica nanoparticles-induced pulmonary fibrosis.
Zhou S; Wang Z; Gao L; Chen M; Duan Y; Zhou P; Liu Z; Wu C; Zhang J; Zhu Q
Int Immunopharmacol; 2023 Dec; 125(Pt B):111112. PubMed ID: 37948857
[TBL] [Abstract][Full Text] [Related]
7. Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor-modulating factors.
Nording H; Baron L; Sauter M; Lübken A; Rawish E; Szepanowski R; von Esebeck J; Sun Y; Emami H; Meusel M; Saraei R; Schanze N; Gorantla SP; von Bubnoff N; Geisler T; von Hundelshausen P; Stellos K; Marquardt J; Sadik CD; Köhl J; Duerschmied D; Kleinschnitz C; Langer HF
Blood Adv; 2023 Nov; 7(21):6411-6427. PubMed ID: 37257194
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Characterization of a New Class of C5aR1 Antagonists Showing
Hubler F; Renneberg D; Siendt H; Stamm S; Hilpert K; Caroff E; Delahaye S; Froidevaux S; Murphy MJ
J Med Chem; 2024 Mar; 67(5):4100-4119. PubMed ID: 38482828
[TBL] [Abstract][Full Text] [Related]
9. Complement C5a Receptor Signaling Alters Stress Responsiveness and Modulates Microglia Following Chronic Stress Exposure.
Chen HC; Spiers JG; Lerskiatiphanich T; Parker SE; Lavidis NA; Fung JN; Woodruff TM; Lee JD
Biol Psychiatry Glob Open Sci; 2024 May; 4(3):100306. PubMed ID: 38628385
[TBL] [Abstract][Full Text] [Related]
10. C5a-C5aR1 Axis Blockade in Patients With Severe COVID-19: Contrasting Results of PANAMO and FORCE.
Carvelli J; Vivier E
Crit Care Med; 2023 May; 51(5):e129-e130. PubMed ID: 37052450
[No Abstract] [Full Text] [Related]
11. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
Ghouse SM; Vadrevu SK; Manne S; Reese B; Patel J; Patel B; Silwal A; Lodhi N; Paterson Y; Srivastava SK; Karbowniczek M; Markiewski MM
J Immunol; 2020 Feb; 204(4):990-1000. PubMed ID: 31900334
[TBL] [Abstract][Full Text] [Related]
12. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach C; MacLean D; Majorova D; Melemenidis S; Nambiar DK; Kim RK; Valbuena GN; Guglietta S; Krieg C; Darvish-Damavandi M; Suwa T; Easton A; Hillson LV; McCulloch AK; McMahon RK; Pennel K; Edwards J; O'Cathail SM; Roxburgh CS; Domingo E; Moon EJ; Jiang D; Jiang Y; Zhang Q; Koong AC; Woodruff TM; Graves EE; Maughan T; Buczacki SJ; Stucki M; Le QT; Leedham SJ; Giaccia AJ; Olcina MM
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824211
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance.
Lawal B; Tseng SH; Olugbodi JO; Iamsaard S; Ilesanmi OB; Mahmoud MH; Ahmed SH; Batiha GE; Wu ATH
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439277
[TBL] [Abstract][Full Text] [Related]
14. Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays
Gorman DM; Li XX; Payne CD; Cui CS; Lee JD; Rosengren KJ; Woodruff TM; Clark RJ
ACS Pharmacol Transl Sci; 2021 Dec; 4(6):1808-1817. PubMed ID: 34927012
[TBL] [Abstract][Full Text] [Related]
15. C5a-C5aR1 Axis Blockade in Patients With Severe COVID-19: Differences Between PANAMO and FORCE Study.
Lim EHT; Vlaar APJ; Brouwer MC; van de Beek D
Crit Care Med; 2023 Nov; 51(11):e243-e244. PubMed ID: 37902353
[No Abstract] [Full Text] [Related]
16. The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemia
Nording H; Baron L; Lübken A; Emami H; von Esebeck J; Meusel M; Sadik C; Schanze N; Duerschmied D; Köhl J; Münch G; Langer HF
TH Open; 2023 Oct; 7(4):e289-e293. PubMed ID: 37868192
[No Abstract] [Full Text] [Related]
17. Complementing Lung Cancer: How Tumor Cells Co-opt the Host Complement System to Reach Bone.
Roman J
Am J Respir Crit Care Med; 2018 May; 197(9):1101-1103. PubMed ID: 29365275
[No Abstract] [Full Text] [Related]
18. CD10
Su S; Chen J; Yao H; Liu J; Yu S; Lao L; Wang M; Luo M; Xing Y; Chen F; Huang D; Zhao J; Yang L; Liao D; Su F; Li M; Liu Q; Song E
Cell; 2018 Feb; 172(4):841-856.e16. PubMed ID: 29395328
[TBL] [Abstract][Full Text] [Related]
19. A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma.
Gallenkamp J; Spanier G; Wörle E; Englbrecht M; Kirschfink M; Greslechner R; Braun R; Schäfer N; Bauer RJ; Pauly D
Oncotarget; 2018 Jan; 9(3):3001-3013. PubMed ID: 29423024
[TBL] [Abstract][Full Text] [Related]
20. Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.
Toomey CB; Landowski M; Klingeborn M; Kelly U; Deans J; Dong H; Harrabi O; Van Blarcom T; Yeung YA; Grishanin R; Lin JC; Saban DR; Bowes Rickman C
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):662-673. PubMed ID: 29392311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
